Replies to post #213586 on Biotech Values

[DewDiligence]

ALDX—( -19%)— sells 3.97M* shares@$7.25—a 20% discount to yesterday’s close:

http://www.prnewswire.com/news-releases/aldeyra-therapeutics-inc-announces-pricing-of-public-offering-of-common-stock-300521989.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

ALDX +30%/PM on phase-2b in dry-eye:

https://www.prnewswire.com/news-releases/aldeyra-therapeutics-announces-positive-results-from-phase-2b-dry-eye-disease-clinical-trial-300718996.html

Phase-3 will start in 2019.